Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
Kangmei Pharmaceutical Statistics
Total Valuation
SHA:600518 has a market cap or net worth of CNY 28.21 billion. The enterprise value is 27.48 billion.
| Market Cap | 28.21B |
| Enterprise Value | 27.48B |
Important Dates
The next estimated earnings date is Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:600518 has 13.83 billion shares outstanding. The number of shares has increased by 33.39% in one year.
| Current Share Class | 13.83B |
| Shares Outstanding | 13.83B |
| Shares Change (YoY) | +33.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 11.47% |
| Float | 9.99B |
Valuation Ratios
The trailing PE ratio is 2,903.93.
| PE Ratio | 2,903.93 |
| Forward PE | n/a |
| PS Ratio | 5.33 |
| PB Ratio | 3.90 |
| P/TBV Ratio | 4.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2,828.31 |
| EV / Sales | 5.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -109.22 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.20 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.52 |
| Interest Coverage | -19.69 |
Financial Efficiency
Return on equity (ROE) is 0.17% and return on invested capital (ROIC) is -3.09%.
| Return on Equity (ROE) | 0.17% |
| Return on Assets (ROA) | -1.62% |
| Return on Invested Capital (ROIC) | -3.09% |
| Return on Capital Employed (ROCE) | -4.60% |
| Revenue Per Employee | 1.25M |
| Profits Per Employee | 2,295 |
| Employee Count | 4,233 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, SHA:600518 has paid 26.08 million in taxes.
| Income Tax | 26.08M |
| Effective Tax Rate | 67.99% |
Stock Price Statistics
The stock price has increased by +4.64% in the last 52 weeks. The beta is 0.63, so SHA:600518's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +4.64% |
| 50-Day Moving Average | 2.06 |
| 200-Day Moving Average | 2.09 |
| Relative Strength Index (RSI) | 47.76 |
| Average Volume (20 Days) | 232,662,775 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600518 had revenue of CNY 5.29 billion and earned 9.71 million in profits. Earnings per share was 0.00.
| Revenue | 5.29B |
| Gross Profit | 778.35M |
| Operating Income | -362.71M |
| Pretax Income | 38.36M |
| Net Income | 9.71M |
| EBITDA | -87.58M |
| EBIT | -362.71M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 902.71 million in cash and 131.64 million in debt, giving a net cash position of 771.07 million or 0.06 per share.
| Cash & Cash Equivalents | 902.71M |
| Total Debt | 131.64M |
| Net Cash | 771.07M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 7.23B |
| Book Value Per Share | 0.52 |
| Working Capital | 1.15B |
Cash Flow
In the last 12 months, operating cash flow was -190.89 million and capital expenditures -60.68 million, giving a free cash flow of -251.57 million.
| Operating Cash Flow | -190.89M |
| Capital Expenditures | -60.68M |
| Free Cash Flow | -251.57M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 14.71%, with operating and profit margins of -6.85% and 0.18%.
| Gross Margin | 14.71% |
| Operating Margin | -6.85% |
| Pretax Margin | 0.72% |
| Profit Margin | 0.18% |
| EBITDA Margin | -1.65% |
| EBIT Margin | -6.85% |
| FCF Margin | n/a |
Dividends & Yields
SHA:600518 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.72% |
| Buyback Yield | -33.39% |
| Shareholder Yield | -33.39% |
| Earnings Yield | 0.03% |
| FCF Yield | -0.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Jun 16, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
SHA:600518 has an Altman Z-Score of 0.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.61 |
| Piotroski F-Score | 3 |